Best in Biotech 28 Oct 2025 The 11 most advanced microbiome players aiming for the gut Take a look at 11 of the top biotech companies working on the development of gut microbiome therapies to treat a range of diseases. October 28, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 1 Dec 2022 FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA) today has been hailed ‘fantastic news’ by those in the microbiome field. Ferring Pharmaceutical’s product is approved to stop Clostridiodes difficile infection (CDI) in people over 18 and to be given after they have completed an antibiotic treatment for the […] December 1, 2022 - 6 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 14 Nov 2022 MaaT Pharma: leading the charge in microbiome therapeutics The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business officer at the French biotech MaaT Pharma outlines the firm’s efforts to blaze a trail in clinical testing and manufacturing in the new field. The microbiome world recently made a regulatory step forward as Australia greenlit a stool transplant developed […] November 14, 2022 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 May 2021 Startup Creator Launched to Fill Europe’s Microbiome Translational Gap With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the goal of priming the translational pump in hot areas where European academics have already made a mark, particularly the microbiome. Strong public funding in Europe often generates great science, but the relative lack of private funding resources leaves more opportunities […] May 28, 2021 - 6 minutesmins - By Mark Zipkin Share WhatsApp Twitter Linkedin Email
News and Trends 17 Dec 2020 Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American Society of Hematology (ASH) displayed the achievements of many innovative treatments for blood conditions, including gene and cell therapies. A sweeping new wave of Covid-19 infections that is forcing new lockdowns across the northern hemisphere is already reshaping the biotech […] December 17, 2020 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 1 Sep 2020 Microbiome Therapies Threatened by Covid-19 Restrictions Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of stool samples. Though these measures are now loosening in France, key safety challenges remain for companies using fecal microbiota. Fecal microbiota transplants — procedures where healthy individuals donate their gut microbes to a patient — have changed how we treat […] September 1, 2020 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 5 Feb 2020 MaaT Pharma’s Microbiome Cancer Treatment Given €18M Boost French company MaaT Pharma has raised €18M in Series B financing that will support phase Ib and II trials of its biotherapeutic drug, which aims to restore the microbiome and improve outcomes in patients with various types of blood cancer and solid tumors. The financing round included French microbiome-focused investor Symbiosis, as well as support […] February 5, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jul 2019 The Top 10 Biotechs You’ll Find in Lyon Lyon is one of the hotspots for biotech in Europe. Here are 10 of the most successful biotech companies in this beautiful French city. The second largest city in France (after Paris), Lyon boasts a thriving biotech ecosystem. In addition to the young startups and large biotech companies in the city, Lyon is also the […] July 10, 2019 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2019 Will US Fecal Transplant Death Impact European Biotech? The death of a US patient from complications after a fecal transplant last week could have a major impact on microbiome research in Europe. The microbiome is a field with big potential for treating disease by targeting imbalances in the patient’s gut flora, such as by giving patients the stool bacteria of a healthy person […] June 21, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 22 May 2019 Microbiome Companies Unite to Push for EU Regulation Reform European microbiome biotechs have launched a collaboration to streamline the EU’s regulatory pathways for microbiome-based treatments, which have the potential to treat inflammatory disease and bacterial infection. The companies will propose EU regulatory changes that make it easier to commercialize treatments based on targeting a patient’s microbiome bacteria. Microbiome-based treatments form a young field in […] May 22, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 22 Jan 2019 No Guts, No Glory: How Microbiome Research is Changing Medicine Scientists are uncovering many ways that the microorganisms that share our body can influence our health. It appears as though the human microbiome could be the key to treating all sorts of diseases, but how can we make these tiny creatures collaborate with us? Let’s do a gut check. We’ve all been told that our […] January 22, 2019 - 10 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2018 Microbiome Therapy Shows Early Promise in Cancer Patients A clinical trial run by MaaT Pharma has shown that restoring the microbiome of patients undergoing chemotherapy has potential to improve the outcome of patients with the blood cancer acute myeloid leukemia (AML). The microbes living in our gut can have a big influence on the success of cancer treatments. Some microorganisms are known to […] December 4, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email